This article provided only cursory information about a study that adds to the existing literature about dietary interventions for Alzheimers prevention. While providing a fairly complete framework for what would be included in this style diet, it did not offer a balanced view of the real potential for benefit.
The story said that said that “People who followed the diet were up to 40 percent less likely than those who largely avoided it to develop Alzheimer’s during the course of the research.” The story shouldn’t make the reader do the math to figure out the absolute risk reduction between the groups. See the importance of “absolute vs. relative risks,” explained in a link by that name on the home page under “Things You Should Know About Research Stories.”
The story didn’t explain how or if the researchers monitored adherence to the diet during the trial.
It would be useful to provide additional context (even from quotes from experts in the field) so that readers can better evaluate the evidence as they consider making dietary changes. Comparisons between benefits from dietary changes and those beneftis from other preventive strategies would also be helpful in putting this into context.
No costs of the diet were mentioned. Does choosing such a diet cost more, less, about the same?
The story didn’t explain the differing incidence of Alzheimer’s disease in the groups following different versions of a Mediterranean-style diet.
The story said that 2258 people were studied, and 262 developed Alzheimer’s disease. In a separate place, it said that ” People who followed the diet were up to 40 percent less likely than those who largely avoided it to develop Alzheimer’s during the course of the research.” The story shouldn’t make the reader do the math to figure out the absolute risk reduction between the groups. See the importance of “absolute vs. relative risks,” explained in a link by that name on the home page under “Things You Should Know About Research Stories.”
Finally, the story didn’t explain how or if the researchers monitored adherence to the diet during the trial.
The story explained where the research was published. It also included interview material with the lead author of that paper and with an Alzheimer’s Association spokesperson.
This article did not mention any of the other interventions, similar to the Mediterranean-style diet, that are under investigation as potential means to protect against Alzheimer’s disease.
Although the article makes it sound like the study involved a specific test diet, the study actually involved older people who self-selected their diet. A Mediterranean-style diet is something that anyone can choose. It is relatively easy for consumers to learn how to eat a Mediterranean-style diet, via the Internet or books. Though there is currently no diet that has FDA approval for the claim that it reduces the risk of Alzheimer’s disease, this was not mentioned in the article.
While this article was an attempt to highlight the results of a recent study, the study was not conducted in a vacuum. The idea that a Mediterranean-style diet may be associated with decreased risk for developing Alzheimer’s disease is not new. Several papers have suggested that this diet might help prevent Alzheimer’s disease and there have been a few epidemiological studies that support that idea. It would be useful to put this study into context to help readers understand that these results are in line with findings from other research.
We can’t be sure if the story relied solely or largely on a news release.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like